Cencora, Inc. reported Q2 2026 revenue of $78.3 billion, missing estimates by $2.68 billion and lowering its full-year growth forecast. The company cited $2 billion in revenue loss due to price reductions. Following the earnings release, Cencora's stock dropped 17.4%, triggering an investigation by Pomerantz LLP into possible securities fraud by the company and its executives. Investors are advised to contact the law firm regarding potential class action participation.
Apple Inc. has demonstrated solid recent performance with a 3.25% gain over the past 30 days, though it faced a slight 1.99% decline in the last 10 days. Analysts remain optimistic, projecting a 7.15% growth potential and setting an average target pr...
On June 5, during Nasdaq's worst single-day drop in over a year, retail investors mostly bought the dip in well-known AI and hardware stocks like Tesla, Nvidia, and CoreWeave. However, six major tech stocks including Amazon, Microsoft, and Alphabet s...
Analyst John Roque highlights the 2-year Treasury yield approaching 5% as a major risk for momentum-driven assets like AI chip stocks, gold, silver, and Bitcoin. Recent sharp corrections in semiconductor stocks and stretched valuations in markets lik...
Incyte Corporation will acquire Vega Therapeutics for up to $2 billion to expand its portfolio into bleeding disorder treatments, including a late-stage drug candidate for von Willebrand disease. Analyst firm Oppenheimer maintained a "Perform" rating...
Diraq, a pioneer in silicon-based quantum computing, has appointed Scott A. McGregor, former Broadcom CEO, as Chairman of the Board to support its US expansion and product launch by 2029. McGregor's semiconductor expertise aligns with Diraq's goal to...
